Back
Denali Therapeutics, Inc. 10K Form
Buy
75
DNLI
Denali Therapeutics, Inc.
Last Price:
$20.12
Seasonality Move:
-5.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-07 | 10Q | DNLI/Denali Therapeutics, Inc. Quarterly |
| 2020-05-07 | 10Q | DNLI/Denali Therapeutics, Inc. Quarterly |
| 2020-02-27 | 10K | DNLI/Denali Therapeutics, Inc. Annual |
| 2019-11-06 | 10Q | DNLI/Denali Therapeutics, Inc. Quarterly |
| 2019-08-06 | 10Q | DNLI/Denali Therapeutics, Inc. Quarterly |
| 2019-05-08 | 10Q | DNLI/Denali Therapeutics, Inc. Quarterly |
Receive DNLI News And Ratings
See the #1 stock for the next 7 days that we like better than DNLI
DNLI Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-105.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.32 |
| Price / Book: | 3.01 |
Profitability
| EPS (TTM): | -2.91120 |
|---|---|
| Net Income (TTM): | $-498.7M |
| Gross Margin: | $-7.8M |
| Return on Equity: | -44.34% |
| Return on Assets: | -39.45% |
Denali Therapeutics, Inc. Earnings Forecast
Key Denali Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 10 years have been positive in 3 years.
Denali Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DNLI |
| CUSIP: | 24823R |
| Website: | denalitherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 9.79 |
| Quick Ratio: | 9.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DNLI Technical Analysis vs Fundamental Analysis
Buy
75
Denali Therapeutics, Inc. (DNLI)
is a Buy
Is Denali Therapeutics, Inc. a Buy or a Sell?
-
Denali Therapeutics, Inc. stock is rated a BuyThe current Denali Therapeutics, Inc. [DNLI] share price is $19.00. The Score for DNLI is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.